| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |